|As stated numerous times, the shares are now trading, as expected, with some overreach due to hedge positions and shorts. We should get back to the $28 level BY or WITH AA BlA Readout acceptance, setting the shares up for a move into the 30's or higher upon final approval of the science. Yes, biotech and small cap run is helping, and should continue to help now that Santa Claus is here. Best not to trade this now. In fact, my final trading shares were sold yesterday. I moved some to my core position, which will not be touched until we get the FDA acceptance of BLA and/or the stock trades in the $28 level. I'll then sell 1/3rd, giving me a very nice profit and putting me back to my original core position of share count. Oh, by the way, thank you Santa. Hope we've now put the nervous Nellie's in the back room and the negative Karma posters into the pasture. Yes, we will see some short term up and down, as with most stocks that built up such a large option position and naked shorts. Of course, watch out for unexpected moves that the boogie man might make. He/She is a crafty b....... All asset classes are overvalued, IMO, and we would fall some with a general market downturn. No reading on a buyout, and, at this point, who cares about speculating on this. It will be what it will be and we have no influence on it or knowledge. What we know is that the science is to our liking, those in need of it are wanting, and the run in the stock, to date, has been very good to those that traded it or took advantage of it to increase their positions. Hope Santa comes to all and the boogie man is overcome by the powers of good that surround this science. |
Ahhh, you ask, what is his intent. Not saying, as now is the season to be jolly, Fa La La La La. Done.